Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs / European Monitoring Centre for Drugs and Drug Addiction, EMCDDA
Autor institucional: EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTIONIdioma: Inglês.Publicação: Luxembourg : Office for Official Publications of the European Communities, 2002Descrição física: 92 p.; 21 cmISBN: 9291681229Assunto: 103892 | 410454 | 320915 | 229150 | 321506 | 324041Resumo: Foreword. Abbreviations. Introduction. report on the risk assessment of GBH in the framework of the joint action on new synthetic drugs. Europol-EMCDDA progress report on GHB in accordance with Article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of GHB as a medicinal product (EMEA). Review of the pharmacotoxicological data on gamma-hydroxybutyric acid (GHB). Sociological and criminological (Europol) evidence on the risks of GHB. Public health risks of GHB - epidemiological evidence. References. Participants in the risk-assessment process.| Item type | Current location | Call number | Copy number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Monografias | Biblioteca da Polícia Judiciária | PJ19.D.89 (Browse shelf) | PJ28090 | Available | PJ128090 |
Foreword. Abbreviations. Introduction. report on the risk assessment of GBH in the framework of the joint action on new synthetic drugs. Europol-EMCDDA progress report on GHB in accordance with Article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of GHB as a medicinal product (EMEA). Review of the pharmacotoxicological data on gamma-hydroxybutyric acid (GHB). Sociological and criminological (Europol) evidence on the risks of GHB. Public health risks of GHB - epidemiological evidence. References. Participants in the risk-assessment process.
There are no comments for this item.